A new-class of antimalarial medication called KLU156 was just found to be as reliable as exiting treatments, and may be ...
bne IntelliNews on MSN
New jet engines compounds Russia’s glide bomb headache for Ukraine
By Ben Aris in Berlin The Russian air force is lobbing as many as 5,000glide bombs at Ukrainian positions every month, ...
MedPage Today on MSN
Two New Malaria Treatments Show Promise as Drug Resistance Grows
Ghyslain Mombo-Ngoma, MD, PhD, led a study in Gabon in which researchers gave a single-dose treatment combining an ...
Five-year grant of $7 million annually to the academic researchers is aimed at accelerating the development of new therapeutics to combat resistant fungal infections, including the Company’s next ...
Attorney Chad Cummings reveals wealthy clients treat money as a weapon for control, focus on terms over price, buy time ...
Dr. Ghyslain Mombo-Ngoma led a study in Gabon in which researchers gave a single-dose treatment combining an artemisinin with ...
5don MSN
Halting pancreatic cancer spread: Protein-degrading drugs show promise in preclinical models
Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade ...
Young and the Invested on MSN
These 10 index funds are better than the rest
It's difficult to put an exact price tag on how much index funds have saved investors since their creation in 1975. But it's ...
A surprise move by Congress to ban most hemp-derived THC products is sending shockwaves through Colorado’s hemp industry.
HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback